| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/07/2004 | EP1404365A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 04/07/2004 | EP1404364A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity |
| 04/07/2004 | EP1404362A2 Signal-1/signal-2 bifunctional peptide inhibitors |
| 04/07/2004 | EP1404361A1 Mixtures of growth hormone drug-oligomer conjugates compromising polyalkylene glycol, uses thereof, and methods of making same |
| 04/07/2004 | EP1404358A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 04/07/2004 | EP1404354A2 Chemically-modified progenipoietin conjugates |
| 04/07/2004 | EP1404353A2 Methods of using a hyaluronan receptor |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404279A2 Mutant forms of cholera holotoxin as an adjuvant |
| 04/07/2004 | EP1404178A1 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 04/07/2004 | EP1399180A4 Sulfated ccr5 peptides for hiv-1 infection |
| 04/07/2004 | EP1234031A4 B7-h1, a novel immunoregulatory molecule |
| 04/07/2004 | EP1218404A4 A binding motif of a receptor |
| 04/07/2004 | EP1151004B1 Method for producing il-1ra, a therapeutically active protein from body fluids |
| 04/07/2004 | EP1100900B1 Xiap ires and uses thereof |
| 04/07/2004 | EP1087783B1 Use of gastrin fragments or synthetic analogs of gastrin for the manufacture of a medicament for the treatment of helicobacter pylori-associated disorders |
| 04/07/2004 | EP0979277B1 Novel human tumour suppressor gene |
| 04/07/2004 | EP0889905B1 Cytokine antagonists and agonists |
| 04/07/2004 | EP0854914B1 Live vaccines against gram-negative pathogens, expressing heterologous o-antigens |
| 04/07/2004 | EP0787148B1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 04/07/2004 | EP0726955B1 Chimeric proteins comprising borrelia polypeptides: uses therefor |
| 04/07/2004 | EP0683791B1 Aqueous protein composition, glycoprotein contained therein, prepration method therefor and uses thereof |
| 04/07/2004 | EP0549742B1 USE OF CANPs-INHIBITORS IN PHARMACEUTICAL PREPARATIONS |
| 04/07/2004 | CN1487999A Paramyxovirus vector encoding angiogenesis gene and utilization thereof |
| 04/07/2004 | CN1487997A Gene HD3A inducing flowering of plant and utilization thereof |
| 04/07/2004 | CN1487996A Transgenic transchromosomal rodents for making human antibodies |
| 04/07/2004 | CN1487953A Recepter in the EDb Fibronection domain |
| 04/07/2004 | CN1487952A Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 04/07/2004 | CN1487951A Peptides having affinity for the GP 120 viral protein and use thereof |
| 04/07/2004 | CN1487841A Lentiviral vector-mediated gene transfer and uses thereof |
| 04/07/2004 | CN1487840A Molecular antigen array |
| 04/07/2004 | CN1487839A Collectins as adjuvants |
| 04/07/2004 | CN1487838A Molecular antigen array |
| 04/07/2004 | CN1487086A Purification method of recombinant yeast strain and rhGM-CSF to express human granulocyte-macrophage colony stimulating factor |
| 04/07/2004 | CN1487081A Cloning and expression of Baimei pit viper Aidingbit CDNA for treating tumor |
| 04/07/2004 | CN1486989A Technological process of separating and purifying lactoferritin from cow colostrum |
| 04/07/2004 | CN1144875C OMP 26 antigen of haemophilus influenzae |
| 04/07/2004 | CN1144874C Production of enzymatically active recombinant carboxypeptidase B |
| 04/07/2004 | CN1144817C Novel human 'beta' 2 integrin 'alpha' sub unit |
| 04/07/2004 | CN1144816C Novel antproliferative protein from bacillus thuringiensis var. Thuringiensis |
| 04/07/2004 | CN1144815C Modified i CE.(oli) enterotoxin II signal peptide and microorganism expressing fusion protein of said peptide and heterologous protein |
| 04/07/2004 | CN1144584C Sustained-release compositions and method for preparing the same |
| 04/06/2004 | US6717035 Insect resistance; genome comprising nucleic acid sequence 4 |
| 04/06/2004 | US6717034 Altering transcription factor levels |
| 04/06/2004 | US6717031 Method for selecting a transgenic mouse model of alzheimer's disease |
| 04/06/2004 | US6716974 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 04/06/2004 | US6716968 Apoptosis-related antigenic compounds of specified amino acid sequence; inhibition of cell apoptosis; antibodies for stimulation of cell apoptosis; immunoassay to determine rate of apoptosis in tissues |
| 04/06/2004 | US6716967 Purified monoclonal antibody or binding portion thereof that specifically binds to a rupestris stem pitting associated virus coat protein or coat protein polypeptide |
| 04/06/2004 | US6716965 Adipocyte complement related protein zacrp13 |
| 04/06/2004 | US6716964 CtIP, a novel protein that interacts with CtBP and uses therefor |
| 04/06/2004 | US6716961 Chiral peptide nucleic acids with a N-aminoethyl-d-proline backbone |
| 04/06/2004 | US6716824 Antitumor |
| 04/06/2004 | US6716816 Dyslipidemia, hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock. |
| 04/06/2004 | US6716811 Low white blood cell titer |
| 04/06/2004 | US6716810 Composition and method for regulation of body weight and associated conditions |
| 04/06/2004 | US6716809 Antitumor |
| 04/06/2004 | US6716631 Evolution of whole cells and organisms by recursive sequence recombination |
| 04/06/2004 | US6716626 Also a kit for detecting the presence of mrna encoding fgf-21 in a sample from a patient containing the polynucleotide |
| 04/06/2004 | US6716625 Histidine kinases of Aspergillus and other fungal species, related compositions, and methods of use |
| 04/06/2004 | US6716623 Compositions and methods for identifying antigens which elicit an immune response |
| 04/06/2004 | US6716621 Isolated DNA or gene responsible for Parkinson's disease |
| 04/06/2004 | US6716607 Chicken interferon gene and novel recombinant DNA |
| 04/06/2004 | US6716606 For use in hematopoietic therapy; for arresting proliferation of leukemic cells |
| 04/06/2004 | US6716603 Nucleic acids encoding a chloride channel protein |
| 04/06/2004 | US6716601 Controlling the expression of homologous and heterologous nucleic acid molecules in yeast cells. |
| 04/06/2004 | US6716600 Persephin and related growth factors |
| 04/06/2004 | US6716597 Methods and products for regulating cell motility |
| 04/06/2004 | US6716591 B. burgdorferi polypeptides |
| 04/06/2004 | US6716587 Antiinflammatory |
| 04/06/2004 | US6716586 Insulin-like growth factor agonist molecules |
| 04/06/2004 | US6716583 Methods of producing nucleic acid ligands |
| 04/06/2004 | US6716576 Method of assaying Neutrokine-α mRNA level |
| 04/06/2004 | US6716575 Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
| 04/06/2004 | US6716574 Osp-C derived peptide fragments |
| 04/06/2004 | US6716433 Group a streptococcal vaccines |
| 04/06/2004 | US6716432 Altered and purified pneumolysin, substantially non-toxic and capable of eliciting protective immune response against pneumococcal bacteria in animal, comprising specified polypeptide with one to three amino acid substitutions |
| 04/06/2004 | US6716431 Rotavirus nonstructural protein 4 in which histidine or asparagine at amino acid position 47 is mutagenized to aspartic acid to produce alternative form which has reduced toxicity, while retaining its antigenicity and immunogenicity |
| 04/06/2004 | US6716430 Moderating immunology response |
| 04/06/2004 | US6716429 Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp 41 glycoprotein ectodomain |
| 04/06/2004 | US6716428 Synthetic peptides mimick epitope regions of hormones such as human chorionic gonadotropin can be conjugated to carrier; contraceptives, anticarcinogenic agents |
| 04/06/2004 | US6716423 Diagnostic assays for detection of neospora infections in cattle; administering immunogen; breeding |
| 04/06/2004 | CA2269077C Keratinocyte growth factor-2 products |
| 04/06/2004 | CA2257122C Method of activating denatured protein |
| 04/06/2004 | CA2196296C Production of tissue factor pathway inhibitor |
| 04/06/2004 | CA2147372C Multidrug resistance gene |
| 04/06/2004 | CA2089563C Oligonucleotide modulation of cell adhesion |
| 04/06/2004 | CA2087286C Thioether conjugates |
| 04/06/2004 | CA2042016C Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 04/06/2004 | CA2010321C Lymphocyte-associated cell surface protein |
| 04/02/2004 | WO2004031372A1 Insulin-secreting immortalized liver cell line modified by glucose sensitivity |
| 04/02/2004 | CA2435274A1 Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity |
| 04/01/2004 | WO2004027092A2 Dna chips used for bioprocess control |
| 04/01/2004 | WO2004027079A2 Nuclear factor of activated t cells receptor |
| 04/01/2004 | WO2004027070A2 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 04/01/2004 | WO2004027068A2 Systems for expressing toxic proteins, vectors and method of producing toxic proteins |
| 04/01/2004 | WO2004027067A2 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 04/01/2004 | WO2004027066A2 Chimeric recombinant protein and in vitro diagnosis of hiv |
| 04/01/2004 | WO2004027064A2 Ghrh analogues |
| 04/01/2004 | WO2004027061A1 Method of screening remedy for proliferative disease |
| 04/01/2004 | WO2004027058A1 Method of detecting genes specifying allergy predisposition |